GENE ONLINE|News &
Opinion
Blog

BioJapan
Bio Japan 2021 Highlights: The Commercialization of iPS Cells and the Key to Improving Clinical Trials
2022-02-14
Spotlight on Bio Japan 2021: How Data Governance Can Prepare Us for The Future in Global Healthcare
2021-12-09
2021 BioJapan Highlights: How Can Metabolomics and Lipidomics Deepen Microbiome Research?
2021-10-14
Weekly in Asia|Oct-1
2019-10-14
BioJapan 2019 Kicks Off with Importances on New Bioeconomy Strategy
2019-10-10
Highlights on BioJapan 2018 – Updates on the Development of Cell Therapy and the Regenerative Medicine Ecosystem in Japan
2018-10-22
Live Report – 2018 BioJapan: Witness Japan’s biotechnology industry development policy and the innovation of pharmaceutical industry
2018-10-11
LATEST
Flagship-Backed ProFound Launches With $75 Million to Discover Human Proteins
2022-05-27
Janssen’s First Cell Therapy Gets Europe’s Approval for Multiple Myeloma
2022-05-27
Cell and Gene Therapy Landscape in Japan is Moving Beyond Oncology
2022-05-27
New Study Reveals Hope for Recovery of Patients with Spinal Cord Injury
2022-05-27
Laekna Therapeutics Announces Dosing of First Patients in the U.S. and China in Phase Ib/III Study of Afuresertib in Combination with Fulvestrant in HR+/HER2- Breast Cancer
2022-05-26
Stanford Touts Remote-Controllable CAR-T Cell Therapy
2022-05-26
Phenomix Launches The First Obesity Biobank Registry To Study Underling Phenotypes
2022-05-26
EVENT
2022-06-03
ASCO Annual Meeting
Online and on-side
2022-06-07
Digital RESI June
Online
2022-06-09
Medhospafrica
Africa
2022-06-13
BIO International Convention
San Diego, CA
2022-12-14
BIOHK2022
Hong Kong, China
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!